SCLEROSOL (talc)
INTRAPLEURAL SCLEROSING AGENTS · PLEURAL MALIGNANT EFFUSION
BRYAN CORP.
Drug class
Intrapleural Sclerosing Agents
Intrapleural sclerosing agents are therapeutic compounds instilled directly into the pleural space to perform chemical pleurodesis. Read more about Intrapleural Sclerosing Agents
5 drugs in this class 2 manufacturers
Drugs in Intrapleural Sclerosing Agents
STERILE TALC (talc)
INTRAPLEURAL SCLEROSING AGENTS · PLEURAL MALIGNANT EFFUSION
BRYAN CORP.
STERITALC (talc)
INTRAPLEURAL SCLEROSING AGENTS · PLEURAL MALIGNANT EFFUSION
BOSTON MEDICAL
STERITALC (talc)
INTRAPLEURAL SCLEROSING AGENTS · PLEURAL MALIGNANT EFFUSION
BOSTON MEDICAL
SCLEROSOL INTRAPLEURAL (talc)
INTRAPLEURAL SCLEROSING AGENTS · PLEURAL MALIGNANT EFFUSION
BRYAN CORP.
Filter & compare in the drug finder →
Opens the drug finder with Intrapleural Sclerosing Agents preselected. Add indication or manufacturer filters there.
Intrapleural sclerosing agents are therapeutic compounds instilled directly into the pleural space to perform chemical pleurodesis.
They act by provoking localized chemical irritation and inflammation across the visceral and parietal pleural surfaces, which stimulates fibrotic tissue formation and adheres the pleural layers together.
By obliterating the potential pleural cavity, these agents prevent the pathological re-accumulation of air or fluid.
Their primary clinical applications include the management and recurrence prevention of malignant pleural effusions associated with advanced thoracic and metastatic cancers, as well as recurrent pneumothorax.
-
fda.gov
Intrapleural sclerosing agents are therapeutic compounds instilled directly into the pleural space to perform chemical pleurodesis
-
cancer.gov
Intrapleural sclerosing agents are therapeutic compounds instilled directly into the pleural space to perform chemical pleurodesis
-
fda.gov
They act by provoking localized chemical irritation and inflammation across the visceral and parietal pleural surfaces, which stimulates fibrotic tissue formation and adheres the pleural layers together By obliterating the potential pleural cavity, these agents prevent the pathological re-accumulation of air or fluid
-
nih.gov
They act by provoking localized chemical irritation and inflammation across the visceral and parietal pleural surfaces, which stimulates fibrotic tissue formation and adheres the pleural layers together Their primary clinical applications include the management and recurrence prevention of malignant pleural effusions associated with advanced thoracic and metastatic cancers, as well as recurrent pneumothorax
-
fda.gov
By obliterating the potential pleural cavity, these agents prevent the pathological re-accumulation of air or fluid
-
fda.gov
Their primary clinical applications include the management and recurrence prevention of malignant pleural effusions associated with advanced thoracic and metastatic cancers, as well as recurrent pneumothorax
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.